Published

Hemophilia: Novel Tx Also Cuts Bleeding in Kids

Summary by mdedge.com
New research shows that efanesoctocog alfa, a bioengineered factor VIII therapy, is effective and safe in preventing bleeding in children with severe hemophilia A.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.